Teva shares rally as FDA approves troubled drugmaker's migraine treatment | The Times of Israel
Teva, chasing Amgen's Aimovig, scores much-needed FDA approval for migraine drug Ajovy | Fierce Pharma
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
FDA warns of Adderall shortage after Teva manufacturing delay - YouTube
Teva wins FDA nod for once-daily Austedo (NYSE:TEVA) | Seeking Alpha
Regeneron and Teva's fasinumab hit with FDA clinical hold | Fierce Biotech
Teva Pharmaceuticals and MedinCell gain FDA approval for UZEDY, the first subcutaneous, long-acting formulation of risperidone for the treatment of schizophrenia in adults.
FDA approves Teva's generic EpiPen after yearslong delay
Teva Announces FDA Approval of ProAir RespiClick - Drug Discovery and Development
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
Teva_Pharmaceuticals
FDA Roundup AstraZeneca Teva Amgen And More
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
TEVA: Announces FDA Approval of AJOVY® (fremanezumab-vfrm) Injection Autoinjector | FDA Health News
Joshua Russell on LinkedIn: Teva temporarily padlocks a plant after FDA cites it for contamination
Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults | Business Wire
Good news for Teva as FDA expedites novel-class migraine therapy
Teva Pharmaceuticals gets FDA approval for Osteoporosis injection | Eric A. Hughes, MD, PhD posted on the topic | LinkedIn
Medincell stock drops as FDA hits Teva with CRL on long-acting risperidone | BioWorld
FDA Approves Teva's Generic Version of EpiPen Injector - WSJ
